John G. Ullman & Associates’s Precigen PGEN Stock Holding History

John G. Ullman & Associates’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,800	Closed	-$136K	–	131
2018 Q4	$136K	Buy	20,800 +5,800	+39%	+$65K	0.03%	127
2018 Q3	$258K	Buy	+15,000	New	+$223K	0.05%	113
2017 Q3	–	Sell	-8,800	Closed	-$212K	–	115
2017 Q2	$212K	Buy	+8,800	New	+$193K	0.04%	110
2016 Q2	–	Sell	-6,054	Closed	-$203K	–	118
2016 Q1	$203K	Buy	+6,054	New	+$191K	0.05%	99
2015 Q3	–	Sell	-11,934	Closed	-$577K	–	136
2015 Q2	$577K	Sell	11,934 -442	-4%	-$18.6K	0.11%	113
2015 Q1	$537K	Sell	12,376 -142	-1%	-$5.1K	0.1%	111
2014 Q4	$329K	Hold	12,518	–	–	0.06%	123
2014 Q3	$222K	Hold	12,518	–	–	0.04%	138
2014 Q2	$301K	Buy	+12,518	New	+$254K	0.06%	132

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

John G. Ullman & Associates's PGEN Position: Q1 2019 in Review

John G. Ullman & Associates sold out of Precigen (PGEN) in Q1 2019, closing a stake of 20,800 shares — an estimated $136K sold.

John G. Ullman & Associates first reported a position in PGEN in Q2 2014 and held it in 9 quarters. The position peaked at $577K in Q2 2015. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

John G. Ullman & Associates reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
John G. Ullman & Associates sold 20,800 Precigen shares in Q1 2019, an estimated $136K.
John G. Ullman & Associates first reported a position in Precigen in Q2 2014 and held it in 9 quarters.
John G. Ullman & Associates's Precigen position peaked at $577K in Q2 2015.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on John G. Ullman & Associates's 13F filing for Q1 2019, filed 30 Apr 2019.